Combination of everolimus and exemestane improves survival for women with metastatic breast cancer, results show
Thursday, December 8, 2011 - 14:30
in Health & Medicine
In an international Phase III randomized study, everolimus, when combined with the hormonal therapy exemestane, has been shown to dramatically improve progression-free survival, according to research.